Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting
New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
Outcome of Innate Pharma's Annual General Meeting
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021
Innate Pharma Virtual 2021 Annual General Meeting
Innate Pharma First Quarter 2021 Report
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
Innate Pharma files its 2020 Universal Registration Document (document d’enregistrement universel) and 2020 Annual Report on Form 20-F
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
